Nabsys Electronic Genome Mapping Advances Cancer Analysis
Providence, Rhode Island, USA, September 17, 2026 Nabsys, Inc. has announced the publication of research from Augusta University demonstrating...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Providence, Rhode Island, USA, September 17, 2026 Nabsys, Inc. has announced the publication of research from Augusta University demonstrating...
SAN DIEGO, August 10, 2026 Kura Oncology, Inc. announced the publication of new research in Blood detailing the discovery...
INDIANAPOLIS, June 26, 2026 Eli Lilly and Company announced that the European Medicines Agency’s Committee for Medicinal Products for...
BASEL, Switzerland, May 21, 2026 Novartis announced it will present more than 65 company-sponsored and investigator-sponsored abstracts at the...
ROCKVILLE, Md. and SUZHOU, China, May 12, 2026 Ascentage Pharma announced that 17 major clinical advances across its hematology...
LOS ANGELES, April 16, 2026 City of Hope announced that its scientists will present groundbreaking research findings on cancer...
WILMINGTON, DE — November 21, 2025 — Telomir Pharmaceuticals announced new preclinical findings showing that its investigational compound Telomir-1...
